Apply to Cambridge Angels

Apply to Cambridge Angels

ICR Collaborates With AI Drug Discovery Company To Develop Treatments for Rare Childhood Cancer

4 Oct

Written By Alexandra Collingbourne

Alexandra Collingbourne

Dosing complete in Phase I clinical trial of ultra-rapid acting insulin product candidate for diabetes

Ieso plots mental healthcare by AI with launch of Eight Billion Minds